SALL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.88737914186277E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.19559999958818E-07 |
Normal-vs-Stage2 |
2.51321186084397E-12 |
Normal-vs-Stage3 |
1.87339033175249E-12 |
Normal-vs-Stage4 |
4.86721773995669E-13 |
Stage1-vs-Stage2 |
2.16969999999872E-05 |
Stage1-vs-Stage3 |
8.52510000037832E-07 |
Stage1-vs-Stage4 |
1.67235999999349E-05 |
Stage2-vs-Stage3 |
5.579000E-01 |
Stage2-vs-Stage4 |
8.845600E-01 |
Stage3-vs-Stage4 |
6.569400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.81770154483729E-11 |
Normal-vs-AfricanAmerican |
3.510400E-02 |
Normal-vs-Asian |
5.088000E-02 |
Caucasian-vs-AfricanAmerican |
6.284000E-02 |
Caucasian-vs-Asian |
4.335000E-01 |
AfricanAmerican-vs-Asian |
7.179000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.34300356893868E-11 |
Normal-vs-Female |
2.79899999844346E-08 |
Male-vs-Female |
1.499220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.037900E-03 |
Normal-vs-Age(41-60Yrs) |
8.26030022160751E-10 |
Normal-vs-Age(61-80Yrs) |
1.86228810150624E-12 |
Normal-vs-Age(81-100Yrs) |
1.28419996858753E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.587400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.099600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.404300E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.806600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.465600E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.059440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.128800E-01 |
Normal-vs-Grade 2 |
2.70240000377342E-08 |
Normal-vs-Grade 3 |
2.31981100995426E-12 |
Normal-vs-Grade 4 |
1.62503344114384E-12 |
Grade 1-vs-Grade 2 |
1.050600E-01 |
Grade 1-vs-Grade 3 |
4.685800E-02 |
Grade 1-vs-Grade 4 |
1.072430E-02 |
Grade 2-vs-Grade 3 |
2.081800E-02 |
Grade 2-vs-Grade 4 |
3.0332000244826E-09 |
Grade 3-vs-Grade 4 |
4.989200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.07140000099793E-08 |
Normal-vs-ccB subtype |
1.62714286489063E-12 |
ccA subtype-vs-ccB subtype |
3.233600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.00639521558332E-11 |
Normal-vs-N1 |
1.18639997825909E-09 |
N0-vs-N1 |
7.643700E-02 |
|
|